Medifast, Inc. (MED)
NYSE: MED · IEX Real-Time Price · USD
18.64
-0.14 (-0.75%)
At close: Jul 19, 2024, 4:00 PM
19.01
+0.37 (1.98%)
Pre-market: Jul 22, 2024, 4:00 AM EDT
Company Description
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific.
It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.
The company markets its products through point-of-sale transactions, as well as through ecommerce platform.
Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Medifast, Inc.
| Country | United States |
| Founded | 1980 |
| Industry | Personal Services |
| Sector | Consumer Discretionary |
| Employees | 634 |
| CEO | Daniel R. Chard |
Contact Details
Address: 11445 Cronhill Drive Owings Mills, Maryland 21117 United States | |
| Phone | (732) 764-0619 |
| Website | medifastinc.com |
Stock Details
| Ticker Symbol | MED |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000910329 |
| CUSIP Number | 58470H101 |
| ISIN Number | US58470H1014 |
| Employer ID | 13-3714405 |
| SIC Code | 2090 |
Key Executives
| Name | Position |
|---|---|
| Daniel R. Chard | Executive Chairman and Chief Executive Officer |
| James P. Maloney CPA | Chief Financial Officer |
| Anthony E. Tyree | Chief Business Operations Officer |
| Jason L. Groves Esq. | Executive Vice President, General Counsel and Corporate Secretary |
| Nicholas M. Johnson | Chief Field Operations Officer |
| Jonathan Barrett MacKenzie | Vice President of Finance and Chief Accounting Officer |
| Steven Zenker | Vice President of Investor Relations |
| Claudia C. Greninger | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jul 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jul 1, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Jun 21, 2024 | 8-K | Current Report |
| May 8, 2024 | ARS | Filing |
| Apr 29, 2024 | 10-Q | Quarterly Report |
| Apr 29, 2024 | 8-K | Current Report |
| Apr 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 26, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 8, 2024 | 144 | Filing |